| Rare Neoplasm studied in …STUDIED_INderived200 of 361show all (up to 200) |
|---|
| → studied in | NCT07489378recruiting NCI Childhood Cancer Data Initiative (CCDI) Led Pediatric, Adolescent, and Young Adult Rare Cancer Registry for Very Rare Solid Tumors · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Rare Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07529808Phase 1/Phase 2 · recruiting Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Childhood Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07845994Phase 3 · not yet recruiting SEMAFORCRANIO : Multicenter, Double-blind, Parallel, Randomized Controlled Trial of the Efficacy of Semaglutide in Hypothalamic Obesity Secondary to Craniopharyngioma in Children Aged 12 to 17 Years · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Craniopharyngioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03779854Phase 2 · active not recruiting Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04044859Phase 1 · active not recruiting ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS) · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Childhood Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04910685Phase 2/Phase 3 · recruiting (HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Indolent Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02792582Phase 2 · active not recruiting A Phase II Trial of Intensity-Modulated Proton Therapy for Incompletely Resected Craniopharyngioma and Observation for Craniopharyngioma After Radical Resection · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Craniopharyngioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03210714Phase 2 · active not recruiting Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 361 trials mapped (168 active) | — | — | Langerhans Cell Histiocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07835165NA · not yet recruiting A Comparative Study Evaluating the Impact of Intensive Dietary Care on Weight Change and Biological Parameters in Patients Who Underwent Surgery for Craniopharyngioma During the First Postoperative Year · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Craniopharyngioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03698994Phase 2 · active not recruiting Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 361 trials mapped (168 active) | — | — | Histiocytic and Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00044122recruiting Study of Factors Regulating Mast Cell Proliferation · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05786924Phase 1/Phase 2 · recruiting Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Histiocytic and Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04996875Phase 2 · recruiting (Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis · condition mapped CURATED_BROADER · 361 trials mapped (168 active) | — | — | Malignant Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06357377Phase 1 · recruiting A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Childhood Choroid Plexus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07785180recruiting A Non-interventional Study of Participants With BPDCN Treated With Chemotherapy · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03533582Phase 3 · active not recruiting Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Childhood Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04216524Phase 2 · recruiting Venetoclax, SL-401, and Chemotherapy for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06765876early Phase 1 · active not recruiting CART123 T Cells in Relapsed or Refractory CD123+ Hematologic Malignancies: A Dose Escalation Phase I Trial · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07819396Phase 2 · not yet recruiting Depletion of CD45RA Positive Naive T Cells for the Prevention of Graft Versus Host Disease in Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic Syndrome · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07000253Phase 2 · recruiting Timing of Comprehensive Local Treatment After First-Line Systemic Therapy in Oligometastatic Esophageal or Gastric Adenocarcinoma · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Childhood Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07809178not yet recruiting China Treatment Trial for Tumor in Sellar Region With Unruptured Intracranial Aneurysm · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Craniopharyngioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03386513Phase 1/Phase 2 · active not recruiting Study of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCN · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07264959recruiting An Observational Study in Participants With Indolent Systemic Mastocytosis (ISM) · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Indolent Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06690827Phase 1 · recruiting Clinical Trial of CD123-targeted CAR-NK Therapy for Relapse/Refractory AML or BPDCN · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06979895recruiting Investigating Multigene Methylation Dynamics in Treatment Response Surveillance for Gastric Cancer · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Childhood Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07443137Phase 1 · not yet recruiting CAR-T ceLL for Eradication of Active Residual Disease in LBCL (CLEAR-1 Study) · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02159495Phase 1 · active not recruiting Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia and Persistent/Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07321106Phase 1 · recruiting A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Childhood Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02402244recruiting Project: Every Child for Younger Patients With Cancer · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Childhood Langerhans Cell Histiocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07785154recruiting A Registry-study of ELZONRIS in Participants With BPDCN · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06210698recruiting Angioedema Biomarker Research Study · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06620302Phase 1/Phase 2 · suspended Testing the Addition of an Anti-cancer Drug, DT2216, to the Usual Chemotherapy Treatment for Relapsed or Refractory Solid Tumors and Fibrolamellar Carcinoma · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Childhood Fibrolamellar Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07778212NA · recruiting Orelabrutinib Combined With Pola-R-CHP as First-Line Treatment for Patients With Intermediate- to High-Risk DLBCL · condition mapped PROBABILISTIC · 361 trials mapped (168 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01419067Phase 2 · active not recruiting A Phase II Trial of Limited Surgery and Proton Therapy for Craniopharyngioma or Observation After Radical Resection · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Craniopharyngioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07757893not yet recruiting Precision Medicine for Indolent Systemic Mastocytosis (PRISM) · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05919264Phase 1/Phase 2 · recruiting FOG-001 in Locally Advanced or Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Adamantinomatous Craniopharyngioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07440290Phase 2/Phase 3 · recruiting DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers. · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Langerhans Cell Histiocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04013685Phase 1 · active not recruiting Precision-T: A Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07570823Phase 3 · recruiting A Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Gemcitabine and Oxaliplatin in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01396408Phase 2 · active not recruiting A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare Tumours · condition mapped CURATED_BROADER · 361 trials mapped (168 active) | — | — | Rare Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03316573Phase 2 · suspended Pembrolizumab in Neoplasms or Lymphomas · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Histiocytic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05028621NA · suspended Molecular Basis of Langerhans and Non-Langerhans Cell Histiocytic Neoplasms and Castleman Disease · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Langerhans Cell Histiocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07744724Phase 2 · not yet recruiting Pirtobrutinib+Pola-R-CHP for Newly Diagnosed Non-GCB DLBCL · condition mapped PROBABILISTIC · 361 trials mapped (168 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07744737Phase 2 · not yet recruiting Pirtobrutinib + R-CHOP for Untreated Non-GCB DLBCL · condition mapped PROBABILISTIC · 361 trials mapped (168 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07744750Phase 2 · not yet recruiting Pirtobrutinib+Sonrotoclax（PS) Regimen in the Treatment of B-Cell Lymphoma · condition mapped PROBABILISTIC · 361 trials mapped (168 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07749365Phase 2 · recruiting Hypofractionated Radiotherapy Plus GM-CSF, Pomalidomide and Glofitamab for Newly Diagnosed PCNS-DLBCL · condition mapped PROBABILISTIC · 361 trials mapped (168 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06006403Phase 1/Phase 2 · completed Safety and Efficacy of CD123-targeted CAR-NK for Relapsed/Refractory Acute Myeloid Leukemia or Blastic Plasmacytoid Dendritic Cell Neoplasm · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04320888Phase 2 · active not recruiting Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial · condition mapped CURATED_BROADER · 361 trials mapped (168 active) | — | — | Histiocytic and Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06239272Phase 1/Phase 2 · recruiting NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) · condition mapped CURATED_BROADER · 361 trials mapped (168 active) | — | — | Malignant Myoepithelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05362773Phase 1 · active not recruiting A Study of MGD024 in Patients With Relapsed or Refractory Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Aggressive Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03155620Phase 2 · active not recruiting Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial) · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Histiocytic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02523040Phase 2 · active not recruiting Lenalidomide for Adult Histiocyte Disorders · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Langerhans Cell Histiocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07703605not yet recruiting AI-Assisted MRI Molecular Subtyping in Pediatric Brain Tumors · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Craniopharyngioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06013423Phase 2 · recruiting Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07709923completed Predictive Model For Anastomotic Leakage After Colorectal Cancer Surgery · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Childhood Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07712328Phase 4 · enrolling by invitation Randomized Controlled Clinical Study on the Prophylactic Intraoperative Use of Desmopressin in Complex Sellar Region Tumors · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Craniopharyngioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04284774Phase 2 · active not recruiting Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial · condition mapped CURATED_BROADER · 361 trials mapped (168 active) | — | — | Langerhans Cell Histiocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03213652Phase 2 · active not recruiting Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 361 trials mapped (168 active) | — | — | Langerhans Cell Histiocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00449748Phase 2 · completed Everolimus (RAD001) as Therapy for Patients With Systemic Mastocytosis · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03874455no longer available Tazemetostat Expanded Access Program for Adults With Solid Tumors · condition mapped CURATED_BROADER · 361 trials mapped (168 active) | — | — | Malignant Myoepithelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07680933Phase 2 · recruiting Orelabrutinib Combined With Standard Immunochemotherapy With or Without Autologous Hematopoietic Stem Cell Transplantation (Auto-HSCT) for Newly Diagnosed Diffuse Large B-cell Lymphoma (DLBCL) · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04195555Phase 2 · active not recruiting Ivosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 361 trials mapped (168 active) | — | — | Langerhans Cell Histiocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07007052Phase 2 · recruiting Phase II Study Evaluating the Efficacy and Safety of the Combination of Tagraxofusp and Venetoclax in Treatment-naive Blastic Plasmacytoid Dendritic Cell Neoplasm Patients · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07677813Phase 2 · not yet recruiting Orelabrutinib Combined With Induction Therapy Followed by Sequential Monotherapy Maintenance in MCD Subtype Diffuse Large B-cell Lymphoma · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07316101NA · recruiting Clinical Trial of an Anti-Fog Drainage Device for Endoscopic Endonasal Sellar Region Tumor Surgery · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Craniopharyngioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07675967recruiting Clonal Hematopoiesis Chemotherapy and Radiation Effects Study · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Childhood Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07419490NA · recruiting Utero-ovarian Transposition in Patients With Pelvic Malignancies Undergoing Whole Pelvic Radiotherapy · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Childhood Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03194906Phase 2 · completed Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy for Localized Brain Tumors · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Craniopharyngioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07656740not yet recruiting Non-Operative Management and Following Immunotherapy for Colorectal Cancer and Other GI Cancers · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Childhood Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00840047Phase 2 · active not recruiting Methionine PET/CT Studies In Patients With Cancer · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Craniopharyngioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02834013Phase 2 · active not recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Malignant Odontogenic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03113643Phase 1 · recruiting SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03213704Phase 2 · active not recruiting Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 361 trials mapped (168 active) | — | — | Langerhans Cell Histiocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05915208recruiting Histiocytic Disorder Follow-up Study · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Langerhans Cell Histiocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06985576enrolling by invitation Long-term Study to Evaluate Safety and Persistence of GF-CART01 · condition mapped PROBABILISTIC · 361 trials mapped (168 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03017820Phase 1 · recruiting A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Histiocytic and Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03224767Phase 2 · active not recruiting Vemurafenib and Cobimetinib in Treating Patients With BRAF V600E Mutation Positive Craniopharyngioma · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Papillary Craniopharyngioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06026644completed Health-Related Quality of Life Outcomes in Patients With Aggressive B-Cell Lymphomas Treated With CAR-T Cell Therapy in Real Life · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05430971recruiting Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International Registry · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02220985Phase 2 · completed Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04640779Phase 1 · completed Low-Dose Selinexor and Choline Salicylate for Non-Hodgkin or Hodgkin Lymphoma, Histiocytic/Dendritic Cell Neoplasm, or Relapsed or Refractory Multiple Myeloma · condition mapped CURATED_BROADER · 361 trials mapped (168 active) | — | — | Histiocytic and Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06411821Phase 2 · recruiting Ulixertinib in People With Histiocytic Neoplasms · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Histiocytic and Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02860923Phase 3 · completed Efficacy and Safety of Exenatide in the Treatment of Hypothalamic Obesity After Craniopharyngioma Therapy · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Craniopharyngioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05186753Phase 2 · active not recruiting (Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic Mastocytosis · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07462143Phase 2/Phase 3 · recruiting A Phase Ⅱ/Ⅲ Clinical Trial of RC148 Plus Chemotherapy as 1L Therapy for Unresectable or Metastatic Colorectal Cancer · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Childhood Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04087902active not recruiting Long-Term Longitudinal QoL in Patients Undergoing EEA · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Craniopharyngioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07481357Phase 1 · recruiting A First-In-Human Phase I/IIa Study to Evaluate DA 3501 in Patients With Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma and Pancreatic Ductal Adenocarcinoma · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Childhood Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04318678Phase 1 · recruiting CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML) · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03326921Phase 1 · recruiting HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant · condition mapped CURATED_BROADER · 361 trials mapped (168 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01552434Phase 1 · terminated Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Erdheim-Chester Disease | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03246906Phase 2 · terminated Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05028166available Individual Patient Compassionate Use of Mirdametinib · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Histiocytic and Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07562542recruiting Peripheral Blood KIT-D816V Mutation in Adult Systemic Mastocytosis · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07552324Phase 2 · not yet recruiting Study on the Treatment of Double/Triple-hit DLBCL With Chidamide and Lisaftoclax in Combination With Pola-R-CHP · condition mapped PROBABILISTIC · 361 trials mapped (168 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03580655Phase 2 · completed (PATHFINDER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, in Patients With Advanced Systemic Mastocytosis · condition mapped CURATED_BROADER · 361 trials mapped (168 active) | — | — | Malignant Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05233397Phase 2 · recruiting ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Adamantinomatous Craniopharyngioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05465174Phase 2 · recruiting Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Craniopharyngioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03213678Phase 2 · completed Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 361 trials mapped (168 active) | — | — | Langerhans Cell Histiocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07255638recruiting A Non-Interventional Study in Participants With Indolent Systemic Mastocytosis (ISM) in Germany · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Indolent Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01384513Phase 2 · completed A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03213665Phase 2 · completed Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 361 trials mapped (168 active) | — | — | Langerhans Cell Histiocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07211230not yet recruiting Collagenase Biobank Study · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Childhood Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05286788Phase 2 · recruiting MEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Adamantinomatous Craniopharyngioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07511114Phase 3 · not yet recruiting A Study Comparing C Pola R-CHP+X With CR-CHOP in the Treatment of Previously Untreated DEL Under the Guidance of Genotyping · condition mapped PROBABILISTIC · 361 trials mapped (168 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07512726NA · completed DevelopmentA Web-Based Support Care Program for Individuals Diagnosed With Colorectal Cancer · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Childhood Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03526250Phase 2 · completed Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 361 trials mapped (168 active) | — | — | Langerhans Cell Histiocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06327685Phase 1 · recruiting Avapritinib With Decitabine in Patients With SM-AHN · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Systemic Mastocytosis with an Associated Myeloid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03401060Phase 3 · completed Interest of Denosumab Treatment in Osteoporosis Associated to Systemic Mastocytosis · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02450396withdrawn Pregnancy and Medically Assisted Conception in Rare Diseases · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06481826recruiting Glofitamab in Chinese Patients With R/R DLBCL · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07481110recruiting Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Gastric Cancers in Algeria · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Childhood Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03610906enrolling by invitation Prospective Pilot Study Identifying Clinically Relevant Biological Targets for Medical Therapy · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Craniopharyngioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07472621not yet recruiting Real-World Effectiveness and Safety of Glofitamab in Primary Refractory and Early Relapsed Diffuse Large B-Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07474025not yet recruiting Integrating Peritoneal Histological Growth Patterns Into Preoperative Decision-Making for Colorectal Peritoneal Metastses · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Childhood Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03404193Phase 2 · terminated Venetoclax and Decitabine in Treating Participants With Relapsed/Refractory Acute Myeloid Leukemia or Relapsed High-Risk Myelodysplastic Syndrome · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07447050Phase 2 · recruiting Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Childhood Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06896370recruiting An Observational Study for Gastric Cancer in Carriers of High Risk Helicobacter Pylori · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Childhood Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06943794NA · not yet recruiting Eradication of Helicobacter Pylori Subtypes at High Gastric Cancer Risk: a Cluster-randomized Controlled Trial · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Childhood Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06943807recruiting Prospective Gastric Cancer Screening With Fecal Multi-target DNA Analysis · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Childhood Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04134559Phase 2 · recruiting Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Childhood Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07301554not yet recruiting Food Preferences and Craniopharyngiomas · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Craniopharyngioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04907643NA · recruiting Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Childhood Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03970226early Phase 1 · active not recruiting Tocilizumab in Children With ACP · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Adamantinomatous Craniopharyngioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06748001Phase 4 · recruiting Avapritinib Rollover Study · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05093335early Phase 1 · recruiting In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Histiocytic and Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07389356NA · not yet recruiting Modified R-MINE Regimen vs. R-GemOx Regimens on the Treatment of Late Relapsed DLBCL · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03485547Phase 1 · completed Study of Venetoclax, a BCL2 Antagonist, for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01199562active not recruiting Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Mast Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04681105Phase 1 · completed Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies · condition mapped CURATED_BROADER · 361 trials mapped (168 active) | — | — | Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07371663Phase 1/Phase 2 · recruiting An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Childhood Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07361107Phase 1 · recruiting Evaluation of Circulating Immune Response After Histosonics in Colorectal Cancer (ECHO-CRC) · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Childhood Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07356466early Phase 1 · enrolling by invitation Clinical Efficacy of Pucotenlimab Combined With Lenvatinib and SOX Versus SOX Alone in Patients With HER2-Negative Advanced Gastric or Gastroesophageal Junction Adenocarcinoma · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Childhood Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07342686completed Hypothalamic-Stratified Nursing Pathway for Pediatric Craniopharyngioma · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Craniopharyngioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06573723recruiting Institutional Registry of Rare Diseases · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07334431Phase 1/Phase 2 · recruiting Fruquintinib Combined With Trastuzumab and XELOX as First-line Treatment in Patients With HER2-positive Advanced Gastric Cancer · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Childhood Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07328178recruiting Analysis of the Role of IgE Proteoforms in Health and Disease · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07288879Phase 2 · recruiting DALY II Japan/MB-CART2019.1 for DLBCL · condition mapped PROBABILISTIC · 361 trials mapped (168 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07326371Phase 2 · not yet recruiting Glofitamab Combined With CAR-T Therapy in R/R DLBCL · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07312500active not recruiting Fecal DNA Methylation and Helicobacter Pylori SNPs Tests for Gastric Cancer · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Childhood Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00255346Phase 2 · completed Dasatinib as Therapy for Myeloproliferative Disorders (MPDs) · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07306962NA · recruiting Virtual Lesion Segmentation and Mandibular Ameloblastoma Radiographic Safety Margin · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Ameloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07307053Phase 1/Phase 2 · not yet recruiting Rare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2) · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Rare Childhood Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01048281recruiting Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Childhood Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05950802Phase 1 · recruiting Optimizing lymphoDepletion to Improve Outcomes In Patients Receiving Cell Therapy With Yescarta · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07255963Phase 2 · recruiting Pirtobrutinib, Lisaftoclax, and Rituximab in the Treatment of R/R DLBCL · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05051046NA · recruiting Colorectal Cancer Screnning Colonoscopy Under Hypnosis · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Childhood Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05768178Phase 2/Phase 3 · recruiting DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers. · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Erdheim-Chester Disease | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07231250Phase 2 · not yet recruiting Glofitamab Plus Polatuzumab Vedotin and Zuberitamab in Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma · condition mapped PROBABILISTIC · 361 trials mapped (168 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06272461NA · recruiting Comparison of Intravenous Lidocaine vs Ketamine in Colorectal Surgery · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Childhood Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06970145Phase 1/Phase 2 · recruiting Safety and Efficacy of Anlotinib in the Treatment of Recurrent Craniopharyngioma · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Craniopharyngioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02162732NA · completed Molecular-Guided Therapy for Childhood Cancer · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Craniopharyngioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06712810Phase 1 · recruiting Q702 for the Treatment of Patients With Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Histiocytic Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07212933Phase 2 · recruiting The Safety and Clinical Efficacy of RAK Cell Therapy in Late-stage Gastric Cancer: A Randomized Controlled Trial · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Childhood Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07213115completed Epidemiology and Treatment of Gastric Cancer · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Childhood Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05621096Phase 1 · active not recruiting Low Dose Radiation as Bridging Therapy in Relapsed B-Cell Non-Hodgkin Lymphoma · condition mapped PROBABILISTIC · 361 trials mapped (168 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03731260Phase 2 · active not recruiting (PIONEER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, Versus Placebo in Patients With Indolent Systemic Mastocytosis · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Indolent Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04079179Phase 2 · recruiting Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Langerhans Cell Histiocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07177482NA · recruiting ImmunoPET Targeting Trophoblast Cell-surface Antigen 2 (Trop-2) in Craniopharyngioma Patients · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Craniopharyngioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07142473recruiting Mastocytosis From Pediatric Age to Adulthood: Local Registry of Cutaneous and Systemic Mastocytosis · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Cutaneous Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06683846Phase 2 · recruiting Ivonescimab in the Treatment of Multiple Advanced Tumors · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Rare Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06299891Phase 2 · recruiting Efficacy and Safety of Phentermine/Topiramate in Youth With Hypothalamic Obesity · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Craniopharyngioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06732856Phase 1/Phase 2 · recruiting A Phase Ib/II Trial of Neoadjuvant Zolbetuximab Plus Docetaxel, Oxaliplatin and S-1 Chemotherapy in Patients With Locally Advanced Gastric Cancer · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Childhood Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05581979completed PSMA-PET Imaging of Salivary Gland Tumours and Other Rare Cancers · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Rare Childhood Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06592846completed FERtility After Therapy With Intensive Lymphoma in Young Women: LNH-03 1B, LNH-03 2B, LNH-07 3B, GAINED Follow-up · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05934643completed An Observational Cohort Study to Assess the Postop Activity of Colorectal Patients Undergoing Elective Surgery (PHYSPAL) · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Childhood Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07066436early Phase 1 · not yet recruiting ImmunoMRI for Assessment of Tumor-associated Macrophages · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07057765recruiting Predictive Value of CRP, Albumin, CAR, and mGPS in Treatment Outcomes of DLBCL · condition mapped PROBABILISTIC · 361 trials mapped (168 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02285582recruiting International Rare Histiocytic Disorders Registry (IRHDR) · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Erdheim-Chester Disease | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06943768not yet recruiting Fecal DNA Methylation and Helicobacter Pylori Gastric Cancer Susceptibility Genes Test · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Childhood Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07034508Phase 2 · not yet recruiting A Phase II Trial of 4 vs 6 Cycles of CHP Combined With Polatuzumab Vedotin-Rituximab in Untreated DLBCL Patients With IPI 0-1 · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06997302NA · active not recruiting A Study on the Impact of Intelligent Nutrition Management on Clinical Outcomes in Chemotherapy Patients With Gastrointestinal Malignancies · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Childhood Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06742411Phase 1/Phase 2 · recruiting XELOX Combined With Sintilimab and HBO for Advanced or Metastatic GC/GEJC · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Childhood Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06874426recruiting The Impact of Endoscopic Endonasal Skull Base Surgery on Olfaction · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Craniopharyngioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05609942Phase 1 · terminated Study of Elenestinib (BLU-263) in Advanced Systemic Mastocytosis (AdvSM) and and Other KIT Altered Hematologic Malignancies · condition mapped CURATED_BROADER · 361 trials mapped (168 active) | — | — | Malignant Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06065007active not recruiting Quality of Life and Disease-related Symptoms in Individuals With Systemic Mastocytosis · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Systemic Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06801756recruiting Craniopharyngioma and Pregnancies · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Craniopharyngioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06119789Phase 2 · recruiting Precision Cancer Therapy in Rare Cancers · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Rare Childhood Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06891157Phase 2 · recruiting Chidamide Plus R-CHOP in Newly Diagnosed Double-Expressor Diffuse Large B-Cell Lymphoma With Other Molecular Subtypes · condition mapped PROBABILISTIC · 361 trials mapped (168 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06871527Phase 1/Phase 2 · not yet recruiting Fruquintinib Combined With PD-1 Inhibitor and FOLFOX as First-Line Treatment For Advanced Gastric Cancer · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Childhood Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06872853recruiting Evaluation of Rare and Complex Tumours of the Thoraco-Abdominal and Soft Tissue District · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Rare Childhood Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02879162Phase 2 · completed Durvalumab and Tremelimumab in Patients With Advanced Rare Tumours · condition mapped CURATED_BROADER · 361 trials mapped (168 active) | — | — | Rare Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06858644not yet recruiting Development of a Predictive Model for Gastric Cancer Peritoneal Metastasis and Cachexia Using BUB1 and Radiopathomics Data With Deep Learning · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Childhood Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06316882completed Gastric Cancer Endoscopic Screening in an Intermediate-risk Country - ROGCAS, a Dual-centre Pilot Program · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Childhood Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06833840completed Evaluation of the Expression and Prognostic Role of Tumor Stem Cell Marker SOX2 in Odontogenic Cysts and Tumors · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Odontogenic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01701843Phase 2 · terminated Cromoglicate in Mastocytosis · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Mastocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06151080Phase 2 · recruiting Lenalidomide Combined With G-CHOP in the Treatment of Newly Diagnosed DLBCL With FL · condition mapped PROBABILISTIC · 361 trials mapped (168 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06158399Phase 2 · recruiting AZA Combined With RCHOP in P53-mutated DLBCL. · condition mapped PROBABILISTIC · 361 trials mapped (168 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04423185Phase 2 · recruiting PLATFORM Study of Precision Medicine for Rare Tumors · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Rare Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06819605Phase 2/Phase 3 · not yet recruiting Neoadjuvant Therapy With Conservative Surgery vs. Up-front Conservative Surgery for BRAF V600E-Mutated Ameloblastoma · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Ameloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06452446active not recruiting Telehealth-based Symptom Management for Veterans Treated With Selinexor · condition mapped PROBABILISTIC · 361 trials mapped (168 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05917067completed Fluorescence Imaging of the Parathyroid Glands of Children · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Childhood Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05431621completed Establishment of Molecular Classification Models for Early Diagnosis of Digestive System Cancers · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Childhood Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06734078active not recruiting An Italian Multicenter Retrospective Observational Study to Assess the Clinical Characteristics and the Outcome of Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma Treated With Polatuzumab Vedotin Plus Rituximab (± Bendamustine) Under Named Patient Programme · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03220035Phase 2 · completed Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial) · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Langerhans Cell Histiocytosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00780494Phase 2 · completed Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Childhood Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06741124completed Comparison of Channel Esophagogastrostomy and Double Tract Reconstruction After Laparoscopic-assist Proximal Gastrectomy: A Propensity Score-Matched Analysis · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Childhood Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06763068completed Skeletal Muscle Mass Used to Assess Frailty in Older Gastric Cancer Patients · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Childhood Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06759610NA · completed Effect of Tetracycline Socked Pack on Acceleration of Healing During Marsupialization · condition mapped ONTOLOGY_EXACT · 361 trials mapped (168 active) | — | — | Ameloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06748508Phase 2 · not yet recruiting Comparing the Efficacy of Sintilimab Plus Nab-POF Regimen, Sintilimab Plus XELOX Chemotherapy, and Lenvatinib, Sintilimab Plus XELOX Chemotherapy in the Treatment of HER2-negative, Metastatic Gastric Cancer · condition mapped ALIAS · 361 trials mapped (168 active) | — | — | Childhood Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06026488recruiting Real-World Study of DLBCL With Different Genetic Subtypes · condition mapped PROBABILISTIC · 361 trials mapped (168 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |